FGP
LH icon

Freestone Grove Partners’s Labcorp LH Stock Holding History

Freestone Grove Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
5,653
+1,940
+52% +$510K 0.01% 456
2026
Q1 		$991K Buy
+3,713
New +$1.01M 0.01% 481
2025
Q3 		– Sell
-5,568
Closed -$1.46M – 816
2025
Q2 		$1.46M Sell
5,568
-158,819
-97% -$38.7M 0.01% 396
2025
Q1 		$38.3M Sell
164,387
-47,948
-23% -$11.6M 0.39% 81
2024
Q4 		$48.7M Buy
+212,335
New +$48.7M 0.6% 52

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Freestone Grove Partners's LH Position: Q2 2026 in Review

Freestone Grove Partners increased its Labcorp (LH) stake by 52% in Q2 2026, buying an estimated $510K and bringing the position to 5,653 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #456.

Freestone Grove Partners first reported a position in LH in Q4 2024 and has held it in 5 quarters since. The position peaked at $48.7M in Q4 2024. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Freestone Grove Partners held 5,653 shares of Labcorp worth $1.58M as of Q2 2026.
  • Freestone Grove Partners bought 1,940 Labcorp shares in Q2 2026, an estimated $510K.
  • Labcorp made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #456 holding.
  • Freestone Grove Partners first reported a position in Labcorp in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Labcorp position peaked at $48.7M in Q4 2024.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.